| 1 |
Ferenci P,Fried M,Labrecque D, et al. Hepatocellular carcinoma ( HCC) : a global perspective[J]. J Clin Gastroenterol, 2010, 44(4): 239-245.
|
| 2 |
刘会春.中国原发性肝癌治疗指南解读[J].肝胆外科杂志,2013,12(1):12-15.
|
| 3 |
Sun WB.How is radiofrequency ablation going in treating hepatocellular carcinoma in China? Austral-Asian Journal of Cancer 2008,7(4):221-224.
|
| 4 |
Lau WY,Lai EC.The current role of radiofrequency ablation in the management of hepatocellular carcinoma: a systematic review. Ann Surg, 2009,249(1):20-25.
|
| 5 |
Takayasu K,Arii S,Ikai I, et al: Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8,510 patients. Gastroenterology, 2006, 131:461-469.
|
| 6 |
Jeon SH,Park KS,Kim YH, et al. Incidence and risk factors of acute hepatic failure after transcatheter arterial chemo-embolization for hepatocellular carcinoma[J]. Korean J Gastroenterol, 2007,50(3): 176-182.
|
| 7 |
Lewis AL,Taylor RR,Hall B et al. Pharmacokinetic and safety study of doxorubicin-eluting beads in a porcine model of hepatic arterial embolisation[J]. J Vasc Interv Radiol, 2006, 17:1335–1343.
|
| 8 |
Hong K,Khwaja A,Liapi E, et al. New intra-arterial drug delivery system for the treatment of liver cancer: preclinical assessment in a rabbit model of liver cancer[J]. Clin Cancer Res, 2006, 12 :2563–2567.
|
| 9 |
Varela M,Real MI,Burrel M,et al.Chemoembolisation of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics[J]. J Hepatol ,2007:474–481.
|
| 10 |
Poon RT,Tso WK,Pang RW, et al. A phase I/II trial of chemoembolisation for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead[J]. Clin Gastroenterol Hepatol5 ,2007:1100–1108.
|
| 11 |
Kettenbach J,Stadler A,Katzler IV,et al. Drug-loaded microspheres for the treatment of liver cancer: review of current results[J]. Cardiovasc Interv Radiol,2008:468–476.
|
| 12 |
Malagari K,Chatzimichael K,Alexopo ülou E, et al. Transarterial chemoembolisation of unresectable hepatocellular carcinoma with drug eluting beads: results of an open-label study of 62 patients. Cardiovasc Interv Radiol, 2008:269–280.
|
| 13 |
Diane K. Reyes, BS,* Josephina A. et al. Single-center phase II trial of transarterial chemo-embolization with drug- eluting beads for patients with unresectable hepatocellular carcinoma: initial experience in the United States[J]. Cancer J, 2009,15(6):526-532.
|
| 14 |
Varela M,Real MI,Burrel M, et al. Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics[J]. J Hepatol, 2007, 46:474–481.
|
| 15 |
LOFFROY R,GUIU B,CERCUEIL JP,et al. Endovascular therapeutic embolisation:An overview of occluding agents and their effects on embolised tissues[J]. Curr Vasc Pharmacol, 2009,7(2):250-263.
|
| 16 |
LAURENT A. Microspheres and nonspherical particles for embolization[J]. Tech Vasc Interv Radiol,2007, 10(4):248-256.
|
| 17 |
Myeong Jun Songa,Chung-Hwa Parka,Jin Dong Kima,Hee Yeon Kima,Drug-eluting bead loaded with doxorubicin versus conventional Lipiodol-based transarterial chemoembolization in the treatment of hepatocellular carcinoma: a case–control study of Asian patients[J].European Journal of Gastroenterology & Hepatology, 2011,23:521–527.
|
| 18 |
RENUMATHY DHANASEKARAN,DAVID A. KOOBY,CHARLES A.Comparison of Conventional Transarterial Chemoembolization (TACE) and Chemoembolization With Doxorubicin Drug Eluting Beads (DEB) for Unresectable Hepatocelluar Carcinoma (HCC)[J].Journal of Surgical Oncology, 2010, 101:476–480.
|
| 19 |
van Malensteina Hannah.Geert Maleuxb.Vincent Vandecaveyeb.Onkologie.A Randomized Phase II Study of Drug-Eluting Beads versus Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma, 2011, 34:368–376.
|
| 20 |
杨奎,尹君,雪广.不同介入模式治疗肝癌的比较研究[J]. 临床放射学杂志, 2006, 25 (7): 658-661.
|
| 21 |
Johannes Lammer,Katarina Malagari,Thomas Vogl,et al : Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study[J], Cardiovasc Intervent Radiol, 2010,33:41–52.
|
| 22 |
Mario Scartozzi,Gianluca Svegliati Baroni,Luca Faloppi, et al.Transarterial Chemo-embolization (TACE), with either ipiodol(traditional TACE) or drug-eluting microspheres (precision TACE, pTACE) in the treatment of hepatocellular carcinoma: efficacy and safety results from a large mono-institutional analysis[J]. Journal of Experimental & Clinical Cancer Research, 2010,29:164.
|
| 23 |
RIAD SALEM.ROBERT J. LEWANDOWSKI.Radioembolization for Hepatocellular Carcinoma Using Yttrium-90 Microspheres: A Comprehensive Report of Long-term Outcomes[J]. Gastroenterology. 2010 Jan,138(1):52-64.
|
| 24 |
Laura E. Moreno-Luna·Ju Dong Yang.Efficacy and Safety of Transarterial Radioembolization Versus Chemoembolization in Patients With Hepatocellular Carcinoma[J]. Cardiovasc Intervent Radiol .2013),36:714–723.
|
| 25 |
David A. Kooby, Vasili Egnatashvili, Swetha Srinivasan.Comparison of Yttrium-90 Radioembolization and Transcatheter Arterial Chemoembolization for the Treatment of Unresectable Hepatocellular Carcinoma[J]. J Vasc Interv Radiol 2010,21:224–230.
|
| 26 |
Kent Sato,Robert J. Lewandowski,James T.Treatment of Unresectable Primary and Metastatic Liver Cancer with Yttrium-90 Microspheres (TheraSphere?):Assessment of Hepatic Arterial Embolization.Cardiovasc Intervent Radiol, 2006,29:522–529.
|
| 27 |
邹子扬,赵春梅,李双成, 等. 海藻酸钠微球血管栓塞剂栓塞治疗原发性肝癌临床研究[J]. 临床荟萃, 2006, 21(12):869-870.
|
| 28 |
Rand T,Loewe C,Schoder M, et al. Arterial embolization of unresectable hepatocellular carcinoma with use of microspheres, lipiodol, and cyanoacrylate[J]. Cardiovasc Intervent Radiol, 2005,28(3):313- 318.
|
| 29 |
罗剑钧,颜志平,王建华, 等. 微球+碘化油联合栓塞与碘化油单独栓塞治疗肝癌的比较研究[J]. 中国计算机成像杂志,2008,14(2): 154- 159.
|
| 30 |
陈红栓,白旭明,程龙等.栓塞微球联合碘化油化疗栓塞治疗肝癌的临床研究[J].实用医学影像杂志, 2012, 13(14):266-269.
|
| 31 |
杨积慧,颜志平,王建华, 等. ContourSe微球联合碘油栓塞治疗大肝癌的初步临床研究[J].中国临床医学,2008,15(6):798-801.
|
| 32 |
杨建东,孔曼,黄希芬等.应用海藻酸钠微球联合碘化油经导管肝动脉化疗栓塞治疗肝癌[J].中国介入影像与治疗学, 2010, 7(3):225-227.
|
| 33 |
Takahiro Yamasaki,Satoe Hamabe,Issei Saeki, et al.(2010): A novel transcatheter arterial infusion chemotherapy using iodized oil and degradable starch microspheres for hepatocellular carcinoma: a prospective randomized trial[J]. J Gastroenterol, 2011, 46(3):359-366.
|